Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Mizushima, N
Keating MJ, Estey E, Kantarjian H, O'Brien S, Andreeff M , Freireich EJ
Patients starting GLP-1 therapy through Medicaid receive a one-size-fits-all medication based on administrative criteria, not personalized genetics
Some patients may require lower doses of their blood pressure medication over time
As adoption increases, so does the potential impact on category performance, portfolio strategy and innovation priorities. Further reading: How are GLP-1 drugs impacting spending on food and dietary supplements
US$ 25.02
US$ 21.68
US$ 22.32
US$ 29.76
US$ 24.31
US$ 25.76
US$ 28.02
US$ 29.63
US$ 20.52
US$ 25.76
